EspositoK, CiotolaM, MaiorinoMI, GualdieroR, SchisanoB, CerielloA, BeneduceF, FeolaG, GiuglianoD. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial. Ann Intern Med, 2008; 149:531–539.
2.
PradhanAD, EverettBM, CookNR, RifaiN, RidkerPM. Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. JAMA, 2009; 302:1186–1194.
3.
AasAM, SeljeflotI, TorjesenPA, DiepLM, ThorsbyPM, BirkelandKI. Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes. Diabetologia, 2006; 49:872–880.
4.
MavridisG, SouliouE, DizaE, SymeonidisG, PastoreF, VassiliouAM, KaramitsosD. Inflammatory cytokines in insulin-treated patients with type 2 diabetes. Nutr Metab Cardiovasc Dis, 2008; 18:471–476.
5.
RidkerPM, RifaiN, RoseL, BuringJE, CookNR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347:1557–1565.
6.
LehtovirtaM, ForsénB, GullströmM, HäggblomM, ErikssonJG, TaskinenMR, GroopL. Metabolic effects of metformin in patients with impaired glucose tolerance. Diabet Med, 2001; 18:578–583.
7.
HughesVA, FiataroneMA, FieldingRA, KahnBB, FerraraCM, ShepherdP, FisherEC, WolfeRR, ElahiD, EvansWJ. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol, 1993; 264:E855–E862.
8.
IshiiT, YamakitaT, SatoT, TanakaS, FujiiS. Resistance training improves insulin sensitivity in NIDDM subjects without altering maximal oxygen uptake. Diabetes Care, 1998; 21:1353–1355.
9.
Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002; 346:393–403.
10.
PraetSF, van LoonLJ. Optimizing the therapeutic benefits of exercise in Type 2 diabetes. J Appl Physiol, 2007; 103:1113–1120.
11.
HansenD, DendaleP, van LoonLJ, MeeusenR. The impact of training modalities on the clinical benefits of exercise intervention in patients with cardiovascular disease risk or type 2 diabetes mellitus. Sports Med, 2010; 40:921–940.
12.
MandersRJ, Van DijkJW, van LoonLJ. Low-intensity exercise reduces the prevalence of hyperglycemia in type 2 diabetes. Med Sci Sports Exerc, 2010; 42:219–225.
13.
PraetSF, MandersRJ, LieverseAGet al.Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes. Med Sci Sports Exerc, 2006; 38:2037–2044.
14.
DijkJW, MandersRJ, TummersKet al.Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients. Diabetologia, 2012; 55:1273–82.
15.
GoodyearLJ, KahnBB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med, 1998; 49:235–261.
16.
HenriksenEJ. Invited review: Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol, 2002; 93:788–796.
17.
GotoK, IshiiN, SugiharaS, YoshiokaT, TakamatsuK. Effects of resistance exercise on lipolysis during subsequent submaximal exercise. Med Sci Sports Exerc, 2007; 39:308–315.
18.
CerielloA. Postprandial hyperglycemia and diabetes complications: is it time to treat?Diabetes, 2005; 54:1–7.
19.
SnowlingNJ, HopkinsWG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care, 2006; 29:2518–2527.
20.
BouleNG, HaddadE, KennyGP, WellsGA, SigalRJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA, 2001; 286:1218–1227.
21.
Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet, 2009; 374:1677–1686.
22.
NeumannPJ, RosenAB, WeinsteinMC. Medicare and cost-effectiveness analysis. N Engl J Med, 2005; 353:1516–1522.
23.
EddyDM, SchlessingerL, KahnR. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med, 2005; 143:251–264.
24.
Da SilvaC, RibeiroJ, CantoJ, da SilvaR, SilvaG, BoturaE, MalschitzkyM. High-intensity aerobic training improves endothelium-dependent vasodilation in patients with metabolic syndrome and type 2 diabetes mellitus. Diabetes Res Clin Pr, 2012; 95:237–245.
SnelM, van DiepenJ, StijnenT, PijlH, RomijnJ, MeindersA, VolsholP, JazetI. Immediate and long-term effects of addition of exercise to a 15-week very low calorie diet on low-grade inflammation in obese, insulin-dependent type 2 diabetes patients. Food and Chemical Toxology, 2011; 49:3104–3111.
27.
KornhauserC, MalacaraJM, Macias-CervantesMH, Rivera-CisnerosAE. Effect of exercise intensity on albuminuria in adolescents with Type 1 diabetes mellitus. Diabet Med, 2012; 29:70–3.
